SEC Form 3 · accession 0001209191-15-034128
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ken Bartizal
Officer — Chief Development Officer
Period of report
Apr 14, 2015
Accepted (ET)
Apr 14, 2015 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 61,376 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.86 | holding | — | — | — | Feb 19, 2015 | Feb 18, 2025 | Common Stock | 51,377 | — | D |
Explanation of responses
- F1The option is immediately exercisable, with vesting as follows: The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of February 19, 2015 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date.